Complications/comorbidités
Publié le 16 sep 2015
Incrétines, antidiabétiques oraux et risque de cancer du pancréas
R.W. Thomsen (Danemark) – Risk of pancreatic cancer associated with use of incretin-based therapy and other glucose-lowering agents: a nationwide case-control study in Denmark